Medication info
Donghwa Rosuvastatin Tablets 10 milligrams (Rosuvastatin Calcium)

Donghwa Rosuvastatin Tablets 10 milligrams (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Donghwa Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/PITP[15 tablets/PTPX2]
Approval status
Active

MFDS item code 202002283 · Approved 2020.04.01 · Insurance code 642706880

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17 years): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Ingredients

Manufacturer
Donghwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used for the treatment of hypercholesterolemia and dyslipidemia. It is used as an adjunct for patients with primary hypercholesterolemia, mixed hyperlipidemia, and familial hypercholesterolemia who have difficulty managing their condition through diet and exercise. It also helps lower total cholesterol and LDL-cholesterol levels, thereby delaying the progression of atherosclerosis. It is also used in children and adolescents for the treatment of familial hypercholesterolemia and prescribed as an adjunct to dietary management of primary dysbetalipoproteinemia. In adults at high risk for cardiovascular disease, it effectively reduces the risk of stroke, myocardial infarction, and vascular interventions. Therefore, this medication is used for cholesterol control and cardiovascular health improvement.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17 years): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients with allergies to any of its components, severely impaired liver function, muscle diseases, or severe renal disease. Women who are pregnant or breastfeeding, as well as fertile women not using appropriate contraception, should not use this medication. It can only be administered to women who might become pregnant if the potential risks to the fetus and the lack of probability to become pregnant are thoroughly explained. Additionally, a high dosage is contraindicated in patients at high risk for myopathy or rhabdomyolysis, as well as in patients with moderate to severe renal impairment, hypothyroidism, family history of such conditions, alcoholics, and Asian patients who should use caution when using this medication. This medication contains lactose, so it should not be given to patients with lactose intolerance or related genetic issues. Patients taking this medication should have regular liver function tests and muscle-related examinations, and report any symptoms such as muscle pain, weakness, fatigue, or fever to a healthcare professional immediately. Particularly, when used in combination with other medications, the risk of muscle damage may increase, so patients should discuss any concomitant medications with their healthcare provider. This medication may rarely cause severe skin reactions or liver damage, so if symptoms like rash, jaundice, or severe fatigue occur, patients should stop taking it immediately and consult a physician. Pregnant or breastfeeding women should not use this medication, and women planning to become pregnant should ensure appropriate contraception. In case of overdose, there are no specific antidotes, so treatment should be based on symptoms, and liver function and muscle enzyme levels should be monitored. Dizziness may occur during treatment, so caution should be exercised when driving or operating machinery. Finally, this medication may show higher plasma concentrations in Asians, so dosage adjustments may be necessary.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, drug rash resembling erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to keep air and moisture out, at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its efficacy.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/PITP[15 tablets/PTPX2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.